- Home
- MSC vs PRAX Comparison
MSC vs PRAX Comparison
Compare MSC & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSC | PRAX |
|---|---|---|
| Founded | 2000 | 2015 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 753.1M | 4.0B |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MSC | PRAX |
|---|---|---|
| Price | $2.95 | $271.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $349.79 |
| AVG Volume (30 Days) | 4.1K | ★ 844.2K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $687,148,000.00 | $7,463,000.00 |
| Revenue This Year | $8.92 | N/A |
| Revenue Next Year | N/A | $12,467.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 9.50 | ★ 364.98 |
| 52 Week Low | $2.30 | $26.70 |
| 52 Week High | $6.81 | $286.50 |
Technical Indicators
Market Signals| Indicator | MSC | PRAX |
|---|---|---|
| Relative Strength Index (RSI) | 37.08 | 65.80 |
| Support Level | $2.88 | $262.31 |
| Resistance Level | $3.58 | $286.50 |
| Average True Range (ATR) | 0.16 | 14.00 |
| MACD | -0.03 | -1.31 |
| Stochastic Oscillator | 7.53 | 57.15 |
Price Performance
Historical ComparisonAbout MSC Studio City International Holdings Limited
Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.